Skip to main content
. Author manuscript; available in PMC: 2018 Jan 30.
Published in final edited form as: J Int Neuropsychol Soc. 2017 Aug 4;24(1):91ā€“103. doi: 10.1017/S1355617717000601

Table 4.

Results of Phase 1 comparisons, including 1) ANCOVA between group comparisons (correcting for age, sex, and current medication use) and 2) post-hoc comparisons between estimated marginal means (corrected for covariates) and age-based normative data

ANCOVA ā€“
between group comparisons
Adjusted marginal means from ANCOVA -
Post-hoc comparisons with normative data

Cognitive domains F p-value Eta2 ADHD Mood disorder ASD Psychosis
General Ability Index 1.61 .19 .013 102.9 (12.4)* 107.8 (15.5)* 103.9 (17.5) 101.7 (13.8)
(101.2;104.6) (103.4;112.2) (99.3;108.4) (96.7;106.8)
253 41 34 29
Response Variability** .38 .77 .004 53.8 (10.8)* 53.2 (11.6) 51.9 (12.6) 55.1 (11.2)
(52.3;55.3) (49.3;57.2) (47.8;56.0) (49.9;60.1)
220 35 29 19
Working Memory 1.84 .14 .015 94.8 (12.0)* 97.4 (11.4) 94.9 (16.3) 90.1 (16.2)*
(93.2;96.4) (93.2;101.5) (90.5;99.3) (85.3;94.9)
253 41 34 29
Inhibition** 1.07 .36 .010 52.1 (10.5)* 53.6 (10.4) 54.4 (9.1) 55.7 (10.3)
(50.8;53.5) (50.0;57.2) (50.7;58.1) (51.0;60.4)
220 35 29 19
Shifting .77 .51 .008 8.2 (3.5)* 9.2 (3.5) 8.6 (4.2) 8.5 (3.1)
(7.7;8.7) (8.0;10.4) (7.2;10.1) (7.1;9.8)
219 38 24 28

Note. Values in table represent adjusted marginal means (SD), (95% CI), and sample size from ANCOVA;

*

pā‰¤0.0125 (significant after Bonferroni correction);

Low scores indicate worse performance, with the exception of measures designated with **, in which high scores reflect greater difficulty.